{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:52:10Z","timestamp":1788835930891,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001230","name":"Macquarie University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["WO2019071302"],"award-info":[{"award-number":["WO2019071302"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["WO2019227167"],"award-info":[{"award-number":["WO2019227167"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceutica","doi-asserted-by":"publisher","award":["WO2017004674A1"],"award-info":[{"award-number":["WO2017004674A1"]}],"id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.pnpbp.2026.111629","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T23:26:56Z","timestamp":1769470016000},"page":"111629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A CBD-rich hemp extract is superior to CBD alone in reducing relapse to methamphetamine-seeking in rats"],"prefix":"10.1016","volume":"145","author":[{"given":"La\u00edsa S.","family":"Umpierrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maral","family":"Jkorkozian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila A.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsey L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain S.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Baracz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina J.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathon C.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Cornish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2026.111629_bb0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamapsychiatry.2013.3947","article-title":"Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial","volume":"71","author":"Allsop","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pnpbp.2012.10.024","article-title":"Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test","volume":"41","author":"Almeida","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0015","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1111\/epi.16355","article-title":"Coadministered cannabidiol and clobazam: preclinical evidence for both pharmacodynamic and pharmacokinetic interactions","volume":"60","author":"Anderson","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0020","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1021\/acs.jnatprod.9b00600","article-title":"Pharmacokinetics of Phytocannabinoid acids and anticonvulsant effect of Cannabidiolic acid in a mouse model of Dravet syndrome","volume":"82","author":"Anderson","year":"2019","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0025","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1111\/bph.15181","article-title":"Interactions between cannabidiol and Delta(9) -tetrahydrocannabinol in modulating seizure susceptibility and survival in a mouse model of Dravet syndrome","volume":"177","author":"Anderson","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1021\/acschemneuro.0c00677","article-title":"Cannabichromene, related Phytocannabinoids, and 5-Fluoro-cannabichromene have anticonvulsant properties in a mouse model of Dravet syndrome","volume":"12","author":"Anderson","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0035","doi-asserted-by":"crossref","first-page":"14948","DOI":"10.1038\/s41598-021-94212-6","article-title":"Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations","volume":"11","author":"Anderson","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0040","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1111\/bph.15661","article-title":"Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy","volume":"178","author":"Anderson","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113158","article-title":"Cannabidiol efficiently suppressed the acquisition and expression of methamphetamine-induced conditioned place preference in the rat","volume":"404","author":"Anooshe","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0050","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/FBP.0000000000000565","article-title":"Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice","volume":"31","author":"Assareh","year":"2020","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/bph.70070","article-title":"Cannabidiol dose-dependently reduces alcohol intake in mice via a non-5-HT1A receptor mechanism: exploration of other potential receptor targets","author":"Badolato","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0060","first-page":"305","article-title":"Pharmacological treatments for methamphetamine addiction: current status and future directions","volume":"10","author":"Ballester","year":"2017","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbr.2011.11.038","article-title":"Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamine-induced conditioned place preference","volume":"228","author":"Baracz","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0070","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/adb.12198","article-title":"Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine-seeking behaviour in rats","volume":"21","author":"Baracz","year":"2016","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1089\/can.2020.0073","article-title":"Evaluation of the possible anticonvulsant effect of Delta(9)-Tetrahydrocannabinolic acid in murine seizure models","volume":"7","author":"Benson","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0080","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0085","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12783","article-title":"Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents","volume":"25","author":"Bi","year":"2020","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0090","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0090-9556(25)06664-4","article-title":"Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain","volume":"23","author":"Bornheim","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2004.10.043","article-title":"Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats","volume":"506","author":"Braida","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.drugalcdep.2014.02.702","article-title":"Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors","volume":"139","author":"Brecht","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0105","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0269881120965952","article-title":"Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice","volume":"35","author":"Calpe-Lopez","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103671","article-title":"Effects of Delta(9)-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC:CBD mixtures on behavioral and physiological signs of morphine withdrawal in rhesus monkeys","volume":"392","author":"Carey","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00213-006-0490-4","article-title":"WAY-100635 is a potent dopamine D4 receptor agonist","volume":"188","author":"Chemel","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.173065","article-title":"Cannabidiol (CBD) reduces cocaine-environment memory in mice","volume":"199","author":"Chesworth","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.962922","article-title":"Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer\u2019s disease","volume":"16","author":"Coles","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0130","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/FBP.0000000000000485","article-title":"Optogenetic inhibition of the medial prefrontal cortex reduces methamphetamine-primed reinstatement in male and female rats","volume":"30","author":"Cordie","year":"2019","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0135","series-title":"BEHAVSOFT - Software for Scoring Animal Behavior, in: Industrial, I.-I.N.d.P. (Ed.), Brazil","author":"Costa","year":"2019"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.682","article-title":"Diversity of molecular targets and signaling pathways for CBD","volume":"8","author":"de Almeida","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0145","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","article-title":"A meta-analytic review of psychosocial interventions for substance use disorders","volume":"165","author":"Dutra","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0150","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41386-019-0566-6","article-title":"The effect of chronic oxytocin treatment during abstinence from methamphetamine self-administration on incubation of craving, reinstatement, and anxiety","volume":"45","author":"Everett","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0155","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1177\/02698811221125440","article-title":"Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze","volume":"36","author":"Fabris","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.alcohol.2017.06.004","article-title":"THC inhibits the expression of ethanol-induced locomotor sensitization in mice","volume":"65","author":"Filev","year":"2017","journal-title":"Alcohol"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0166-4328(96)00118-0","article-title":"Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist","volume":"73","author":"Fletcher","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0170","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S2215-0366(20)30290-X","article-title":"Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial","volume":"7","author":"Freeman","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010134","article-title":"Possible receptor mechanisms underlying cannabidiol effects on addictive-like behaviors in experimental animals","volume":"22","author":"Galaj","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107740","article-title":"Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms","volume":"167","author":"Galaj","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0185","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1038\/sj.npp.1301648","article-title":"Context-specific reversal of cocaine sensitization by the CB1 cannabinoid receptor antagonist rimonabant","volume":"33","author":"Gerdeman","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0190","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/s41386-018-0050-8","article-title":"Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle","volume":"43","author":"Gonzalez-Cuevas","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0195","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1177\/0269881118799954","article-title":"Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats","volume":"32","author":"Hay","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0200","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0024-3205(75)90435-X","article-title":"Interactions between cannabidiol and delta9-THC during abstinence in morphine-dependent rats","volume":"17","author":"Hine","year":"1975","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0205","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/appi.ajp.2019.18101191","article-title":"Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: a double-blind randomized placebo-controlled trial","volume":"176","author":"Hurd","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0210","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/acer.15514","article-title":"Cannabidiol alters psychophysiological, craving and anxiety responses in an alcohol cue reactivity task: a cross-over randomized controlled trial","volume":"49","author":"Hurzeler","year":"2025","journal-title":"Alcohol. Clin. Exp. Res. (Hoboken)"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neulet.2008.02.025","article-title":"Protein expression profile in the amygdala of rats with methamphetamine-induced behavioral sensitization","volume":"435","author":"Iwazaki","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0220","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1369-1600.2012.00483.x","article-title":"Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus","volume":"18","author":"Katsidoni","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0225","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuropharm.2018.09.043","article-title":"Repeated cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus","volume":"143","author":"Lujan","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110462","article-title":"CB1 receptor antagonist AM4113 reverts the effects of cannabidiol on cue and stress-induced reinstatement of cocaine-seeking behaviour in mice","volume":"113","author":"Lujan","year":"2022","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0235","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1590\/1516-4446-2020-1416","article-title":"Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study","volume":"43","author":"Meneses-Gaya","year":"2021","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.euroneuro.2021.04.008","article-title":"Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats","volume":"50","author":"Metz","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0245","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.taap.2005.04.007","article-title":"Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats","volume":"209","author":"Milesi-Halle","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0250","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1111\/add.15417","article-title":"Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo-controlled trial","volume":"116","author":"Mongeau-Perusse","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0255","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/13543784.2017.1313229","article-title":"Pharmacotherapeutic agents in the treatment of methamphetamine dependence","volume":"26","author":"Morley","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0260","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2174\/1570159X19666210803091637","article-title":"Current and emerging treatments for methamphetamine use disorder","volume":"19","author":"Moszczynska","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0265","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1111\/bph.14019","article-title":"Tetrahydrocannabinolic acid is a potent PPARgamma agonist with neuroprotective activity","volume":"174","author":"Nadal","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bib401","series-title":"Australian code for the care and use of animals for scientific purposes","author":"National Health Medical Research Council","year":"2013"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0270","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1037\/pha0000272","article-title":"Effects of cannabidiol on alcohol-related outcomes: a review of preclinical and human research","volume":"27","author":"Nona","year":"2019","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0275","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1007\/s11064-021-03350-w","article-title":"Involvement of hippocampal D1-like dopamine receptors in the inhibitory effect of cannabidiol on acquisition and expression of methamphetamine-induced conditioned place preference","volume":"46","author":"Nouri","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0280","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1017\/S0033291719003519","article-title":"Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis","volume":"51","author":"O\u2019Neill","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0285","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00213-004-1825-7","article-title":"Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats","volume":"175","author":"Parker","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0290","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/epi.14629","article-title":"Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models","volume":"60","author":"Patra","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0295","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamapsychiatry.2020.0246","article-title":"Neurobiology, clinical presentation, and treatment of methamphetamine use disorder: a review","volume":"77","author":"Paulus","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0300","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bph.14073","article-title":"Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5-HT1A receptor-mediated suppression of nausea and anxiety in rats","volume":"175","author":"Pertwee","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0305","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00213-017-4626-5","article-title":"Effect of prior foot shock stress and Delta(9)-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats","volume":"234","author":"Rock","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0310","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s12035-018-1143-4","article-title":"Cannabidiol induces rapid and sustained antidepressant-like effects through increased BDNF Signaling and synaptogenesis in the prefrontal cortex","volume":"56","author":"Sales","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0315","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/can.2017.0043","article-title":"Therapeutic effects of prolonged cannabidiol treatment on psychological symptoms and cognitive function in regular Cannabis users: a pragmatic open-label clinical trial","volume":"3","author":"Solowij","year":"2018","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111267","article-title":"Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Delta9-tetrahydrocannabinol in healthy adults who intermittently use cannabis","volume":"257","author":"Spindle","year":"2024","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114004","article-title":"Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment","volume":"177","author":"Stark","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0330","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1038\/sj.npp.1300744","article-title":"Ionotropic glutamate receptors in the ventral tegmental area regulate cocaine-seeking behavior in rats","volume":"30","author":"Sun","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0335","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0340","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/ADM.0000000000000229","article-title":"Sativex associated with Behavioral-relapse prevention strategy as treatment for Cannabis dependence: a case series","volume":"10","author":"Trigo","year":"2016","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190768","article-title":"Nabiximols combined with motivational enhancement\/cognitive behavioral therapy for the treatment of cannabis dependence: a pilot randomized clinical trial","volume":"13","author":"Trigo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0350","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/acer.13964","article-title":"Cannabidiol as a novel candidate alcohol use disorder pharmacotherapy: a systematic review","volume":"43","author":"Turna","year":"2019","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0355","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00213-022-06119-3","article-title":"Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses","volume":"239","author":"Umpierrez","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0385","series-title":"World Drug Report 2024","author":"United Nations Office on Drugs Crime (UNODC)","year":"2024"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0360","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drugalcdep.2007.11.017","article-title":"Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol","volume":"94","author":"Vann","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0365","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1111\/bph.14380","article-title":"Effects of cannabidiol plus naltrexone on motivation and ethanol consumption","volume":"175","author":"Viudez-Martinez","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0370","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41401-018-0032-8","article-title":"Cannabidiol does not display drug abuse potential in mice behavior","volume":"40","author":"Viudez-Martinez","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0375","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12765","article-title":"Gender differences in the effects of cannabidiol on ethanol binge drinking in mice","volume":"25","author":"Viudez-Martinez","year":"2020","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0380","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neuropharm.2016.08.038","article-title":"GABAergic mRNA expression is differentially expressed across the prelimbic and orbitofrontal cortices of rats sensitized to methamphetamine: relevance to psychosis","volume":"111","author":"Wearne","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0390","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/toxres\/tfaa021","article-title":"Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R\/AKT\/GSK-3beta\/CREB signaling pathway in rats","volume":"9","author":"Yang","year":"2020","journal-title":"Toxicol. Res. (Camb.)"},{"key":"10.1016\/j.pnpbp.2026.111629_bb0395","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbr.2015.01.050","article-title":"Oxytocin differentially affects sucrose taking and seeking in male and female rats","volume":"283","author":"Zhou","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111629_bb0400","article-title":"Acute cannabidiol administration reduces alcohol craving and cue-induced nucleus accumbens activation in individuals with alcohol use disorder: the double-blind randomized controlled ICONIC trial","author":"Zimmermann","year":"2024","journal-title":"Mol. Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:35:55Z","timestamp":1776494155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":81,"alternative-id":["S0278584626000254"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111629","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A CBD-rich hemp extract is superior to CBD alone in reducing relapse to methamphetamine-seeking in rats","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111629","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111629"}}